Featured article
ST-Elevation Myocardial Infarction
Cardiovascular
Clinical reference
ST-Elevation Myocardial Infarction
STEMI is a complete occlusion of a coronary artery causing transmural myocardial injury. Time-critical — goal is reperfusion within 90 minutes (PCI) or 30 minutes (thrombolytics).
Terms
0
ICD-10
8
Evidence
5
Trials
8
Latest evidence
Latest evidence
Pre-Hospital and Patient Delays Among Culturally and Linguistically Diverse ST-Segment Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention.
Complete Revascularization Versus Culprit-Only Percutaneous Coronary Intervention in Non-ST-Elevation Myocardial Infarction With Multivessel Disease: A Nationwide Propensity Score-Matched Analysis.
Association of Door-to-Balloon Delay with Complications and Length of Hospital Stays in Patients with ST-Elevation Myocardial Infarction.
Early ambulation before percutaneous coronary intervention in patients with non-ST elevation myocardial infarction: a quasi-experimental study of haemodynamics and clinical outcomes.
Condition family & coding
Terms and documentation support
Condition matches & synonyms
TermsRelated diagnostic names, synonyms, and documentation wording that may appear in clinical references and charting.
No condition suggestions returned.
ICD-10 quick links
CodesFor study support, terminology recognition, and documentation language.
I21.4
Non-ST elevation (NSTEMI) myocardial infarction
I22.2
Subsequent non-ST elevation (NSTEMI) myocardial infarction
I21.29
ST elevation (STEMI) myocardial infarction involving other sites
I21.3
ST elevation (STEMI) myocardial infarction of unspecified site
I21.11
ST elevation (STEMI) myocardial infarction involving right coronary artery
I22.0
Subsequent ST elevation (STEMI) myocardial infarction of anterior wall
I22.1
Subsequent ST elevation (STEMI) myocardial infarction of inferior wall
I22.8
Subsequent ST elevation (STEMI) myocardial infarction of other sites
Common tests
Tests performed
Common medications
Recognize the drug and the class
Related nursing diagnoses
NANDA diagnoses & care plans
Use these direct links to open nursing diagnoses and care-plan support related to ST-Elevation Myocardial Infarction.
Recruiting clinical trials
Additional official research
DCB vs. DES in Young STEMI Patients: The DCB-STEMI Trial
Background: ST Elevation Myocardial Infarction (STEMI) in young adults (\
Effect and Safety of Fexofenadine Hydrochloride vs Placebo in Patients With Acute Myocardial Infaction: A Randomized Clinical Trial
The purpose of this study was to evaluate the efficacy and safety of fexofenadine hydrochloride on the basis of standard treatment after PCI in STEMI patients.
Evaluate the Efficacy and Safety of Allogeneic Umbilical Cord Mesenchymal Stem Cells As an Add-On Treatment for Acute ST-elevation Myocardial Infarction (STEMI) Patients
This phase IIa study is to identify the efficacy and safety of IC(intracoronary) and IV(Intravenous) administrations of UMSC01 in patients with STEMI . This product is a new cell therapy product for treating AMI and produced by Ever Suprem…
Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction
This study is open to adults with ST elevation myocardial infarction (heart attack) undergoing primary percutaneous coronary intervention (PCI). The purpose of this study is to determine whether a medicine called Xolatryp is safe and effec…
Treatment of ACuTe Coronary Syndromes With Low-dose colchICine
This trial is designed to evaluate whether low-dose colchicine, in addition to standard treatment recommended by guidelines, further reduces the risk of major adverse cardiovascular events in patients with acute coronary syndromes (ACS) th…
Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)
This study is a prospective, multicenter, open-label, non-inferiority, randomized controlled trial. A total of 2,000 patients with STEMI (\
Microplastics and Nanoplastics (MNPs) in Patients With ST-elevation Myocardial Infarction (STEMI)
Air pollution and microplastics pose major public health threats. Emerging data have shown that micro- and nanoplastics (MNPs) are ubiquitous environmental pollutants accumulating in human tissues, triggering inflammation and prothrombotic…
OPTIMISER Registry - A Prospective Cohort Study to Describe the OPTIMal Management and Outcomes of PatIents PreSEnting With Acute MyocaRdial Infarction
The purpose of the OPTIMISER Registry is to prospectively and retrospectively collect baseline, clinical and procedural data in patients who present with AMI and are treated with PCI as well as prospectively collect the clinical outcome da…